David Amsellem

Stock Analyst at Piper Sandler

(4.77)
# 124
Out of 5,030 analysts
153
Total ratings
64.46%
Success rate
23.42%
Average return

Stocks Rated by David Amsellem

Supernus Pharmaceuticals
Oct 9, 2025
Upgrades: Overweight
Price Target: $40$65
Current: $50.17
Upside: +29.56%
Amgen
Aug 25, 2025
Maintains: Overweight
Price Target: $328$342
Current: $298.81
Upside: +14.45%
Biogen
Aug 14, 2025
Maintains: Neutral
Price Target: $115$118
Current: $143.00
Upside: -17.48%
AbbVie
Aug 12, 2025
Assumes: Overweight
Price Target: $231
Current: $229.57
Upside: +0.62%
Amphastar Pharmaceuticals
Aug 8, 2025
Maintains: Neutral
Price Target: $30$25
Current: $23.78
Upside: +5.13%
Corcept Therapeutics
Aug 1, 2025
Maintains: Overweight
Price Target: $131$121
Current: $78.69
Upside: +53.77%
Neurocrine Biosciences
Jul 31, 2025
Maintains: Overweight
Price Target: $154$175
Current: $140.09
Upside: +24.92%
Organon & Co.
May 15, 2025
Maintains: Overweight
Price Target: $24$18
Current: $9.28
Upside: +93.97%
Collegium Pharmaceutical
May 9, 2025
Reiterates: Neutral
Price Target: $36$37
Current: $33.96
Upside: +8.95%
Jazz Pharmaceuticals
May 7, 2025
Reiterates: Overweight
Price Target: $176$147
Current: $136.06
Upside: +8.04%
Initiates: Overweight
Price Target: $65
Current: $43.63
Upside: +48.98%
Reiterates: Neutral
Price Target: $3$4
Current: $9.24
Upside: -56.71%
Maintains: Overweight
Price Target: $16$13
Current: $24.48
Upside: -46.90%
Reiterates: Neutral
Price Target: $14$10
Current: $10.17
Upside: -1.67%
Maintains: Overweight
Price Target: $23$30
Current: $19.31
Upside: +55.36%
Maintains: Overweight
Price Target: $24$13
Current: $15.22
Upside: -14.59%
Maintains: Overweight
Price Target: $9$11
Current: $9.92
Upside: +10.89%
Reiterates: Overweight
Price Target: $38$37
Current: $30.26
Upside: +22.27%
Initiates: Overweight
Price Target: $68
Current: $94.79
Upside: -28.26%
Downgrades: Underweight
Price Target: $9$3
Current: $6.05
Upside: -50.41%
Maintains: Overweight
Price Target: $42
Current: $22.86
Upside: +83.73%
Initiates: Overweight
Price Target: $10
Current: $7.08
Upside: +41.24%
Maintains: Overweight
Price Target: $20$21
Current: $1.43
Upside: +1,368.53%
Maintains: Overweight
Price Target: $90$113
Current: $127.94
Upside: -11.68%
Maintains: Overweight
Price Target: $72$42
Current: $25.90
Upside: +62.16%